Logo

Third Wave Sells $14.9M Worth of Convertible Senior Notes

Dec 19, 2006
NEW YORK (GenomeWeb News) — Third Wave Technologies today said it has placed around $14.9 million worth of convertible senior notes with an institutional investor.
 
The company said it plans to use the cash for general corporate purposes.
 
The 6-percent notes, which are convertible into roughly 2.5 million shares, will be due in 2011 and are priced at an initial rate of $6 apiece.
 
Third Wave shares were down 8.2 percent to $4.56 in early-afternoon trading today.

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.